Arrowhead Pharmaceuticals Inc (ARWR)
22.61
+0.08
(+0.36%)
USD |
NASDAQ |
Apr 18, 16:00
22.63
+0.02
(+0.09%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Cash and Short Term Investments (Quarterly): 220.28M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 220.28M |
| September 30, 2023 | 403.63M |
| June 30, 2023 | 451.70M |
| March 31, 2023 | 481.00M |
| December 31, 2022 | 494.53M |
| September 30, 2022 | 376.40M |
| June 30, 2022 | 416.50M |
| March 31, 2022 | 401.90M |
| December 31, 2021 | 330.13M |
| September 30, 2021 | 367.79M |
| June 30, 2021 | 516.31M |
| March 31, 2021 | 577.32M |
| December 31, 2020 | 305.33M |
| September 30, 2020 | 315.49M |
| June 30, 2020 | 287.03M |
| March 31, 2020 | 307.61M |
| December 31, 2019 | 502.00M |
| September 30, 2019 | 258.70M |
| June 30, 2019 | 236.90M |
| March 31, 2019 | 218.20M |
| December 31, 2018 | 243.75M |
| September 30, 2018 | 76.53M |
| June 30, 2018 | 60.48M |
| March 31, 2018 | 91.54M |
| December 31, 2017 | 50.70M |
| Date | Value |
|---|---|
| September 30, 2017 | 65.61M |
| June 30, 2017 | 75.14M |
| March 31, 2017 | 86.63M |
| December 31, 2016 | 102.11M |
| September 30, 2016 | 85.37M |
| June 30, 2016 | 44.65M |
| March 31, 2016 | 61.46M |
| December 31, 2015 | 76.60M |
| September 30, 2015 | 98.75M |
| June 30, 2015 | 110.53M |
| March 31, 2015 | 116.01M |
| December 31, 2014 | 127.52M |
| September 30, 2014 | 154.16M |
| June 30, 2014 | 162.18M |
| March 31, 2014 | 160.65M |
| December 31, 2013 | 75.63M |
| September 30, 2013 | 28.14M |
| June 30, 2013 | 33.08M |
| March 31, 2013 | 3.314M |
| December 31, 2012 | 2.987M |
| September 30, 2012 | 3.484M |
| June 30, 2012 | 2.392M |
| March 31, 2012 | 3.674M |
| December 31, 2011 | 6.845M |
| September 30, 2011 | 8.142M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
220.28M
Minimum
Dec 2023
577.32M
Maximum
Mar 2021
381.61M
Average
376.40M
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 634.13M |
| Viking Therapeutics Inc | 362.08M |
| Akero Therapeutics Inc | 550.01M |
| 89bio Inc | 578.87M |
| Sagimet Biosciences Inc | 94.90M |